An anti-cancer compound developed at USA Health Mitchell Cancer Institute is showing promise in pre-clinical studies – one involving pancreatic cancer and the other involving breast cancer. The compound, MCI-715, was developed by Gary Piazza, Ph.D., and his lab team at the Drug Discovery Research Center at MCI.
About Speech and Hearing Center
USA Health offers a full range of care for speech and hearing issues. Our multidisciplinary team of specialists includes speech pathologists, audiologists, and an ear, nose and throat (ENT) physician. As a comprehensive speech center, we conduct hearing evaluations, voice and swallow evaluations, aphasia therapy for stroke patients and fluency (stuttering) therapy for children. In addition, we program cochlear implants and conduct testing and fittings for hearing aids and other amplification devices.
At the USA Speech and Hearing Center, we treat patients of all ages. Our services include assessment, therapy and treatment for speech, language and hearing conditions, including the following:
Aphasia therapyArticulation therapy Auditory processing Benign paroxysmal positional vertigo (BPPV) Cochlear implant programming Fluency (stuttering) therapy Hearing aid evaluations and fittings Hearing impairment Labyrinthitis (inner ear infection) Meniere's disease Otolaryngology (ear, nose, throat) conditions Swallow therapy Voice evaluations
USA Health Speech and Hearing Center's hours of operation are Monday–Friday, 8 a.m. to 5 p.m.